Phenindione
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00498 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 40 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | thrombotic disease | KG + DL |
| 2 | vein disease | KG + DL |
| 3 | heparin cofactor 2 deficiency | KG + DL |
| 4 | migraine with or without aura, susceptibility to | KG + DL |
| 5 | antithrombin deficiency type 2 | KG + DL |
| 6 | thrombophilia | KG + DL |
| 7 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 8 | migraine disorder | KG + DL |
| 9 | Glanzmann thrombasthenia | KG + DL |
| 10 | lateral sinus thrombosis | KG + DL |
| 11 | cavernous sinus thrombosis | KG + DL |
| 12 | primary release disorder of platelets | KG + DL |
| 13 | migraine with brainstem aura | KG + DL |
| 14 | hemoglobinopathy | KG + DL |
| 15 | pseudo-von Willebrand disease | KG + DL |
| 16 | tendinitis | KG + DL |
| 17 | angiodysplasia | KG + DL |
| 18 | idiopathic granulomatous myositis | KG + DL |
| 19 | myositis fibrosa | KG + DL |
| 20 | venous thromboembolism | KG + DL |
| 21 | fibrocartilaginous embolism | KG + DL |
| 22 | non-inflammatory vasculopathy | KG + DL |
| 23 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 24 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 25 | beta-thalassemia with other manifestations | KG + DL |
| 26 | myocardial infarction (disease) | KG + DL |
| 27 | congenital renal artery stenosis | KG + DL |
| 28 | pyropoikilocytosis, hereditary | KG + DL |
| 29 | pyruvate kinase deficiency of red cells | KG + DL |
| 30 | coronary thrombosis | KG + DL |
| 31 | fibromyalgia | KG + DL |
| 32 | atrophoderma vermiculata | KG + DL |
| 33 | inclusion body myositis | KG + DL |
| 34 | pulmonary embolism (disease) | KG + DL |
| 35 | rheumatoid arthritis | KG + DL |
| 36 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 37 | congenital coronary artery anomaly | KG + DL |
| 38 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 39 | vascular insufficiency disorder | KG + DL |
| 40 | ulerythema ophryogenesis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.